newsfilter
← Latest News
Business Wire·

Gemini Therapeutics Announces Presentation of Preclinical Data at 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

− GEM103 demonstrates anti-angiogenic activity in a mouse model of laser-induced choroidal neovascularization (CNV) Gemini Therapeutics, Inc. (NASDAQ:GMTX), a clinical stage precision medicine company developing innovative treatments for geneticall